Effect of short-term different statins loading dose on renal function and CI-AKI incidence in patients undergoing invasive coronary procedures

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 5101-5103

  Han, Shan ^a   Li, Xi Ming ^a   Mohammed Ali, Lamees Abdullah ^a   Fu, Nai Kuan ^a   Jin, Dong Xia ^a   Cong, Hong Liang ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Contrast nephropathy; Contrast induced acute kidney injury; Coronary artery disease; Coronary intervention; Statins

Indexed keywords

ATORVASTATIN; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITROGEN; PROBUCOL; URIC ACID;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; BEDTIME DOSAGE; CHILD; CONTRAST INDUCED ACUTE KIDNEY INJURY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; INFANT; INVASIVE PROCEDURE; KIDNEY FUNCTION; LETTER; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

CONTRAST NEPHROPATHY; CONTRAST-INDUCED ACUTE KIDNEY INJURY; CORONARY ARTERY DISEASE; CORONARY INTERVENTION; STATINS;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; KIDNEY; MALE; TREATMENT OUTCOME;

EID: 84886447191     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.252     Document Type: Article

References (9)

1. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
2. National Kidney Foundation K/DOQJ. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 Suppl. 1 2002 51 237
3. P.A. McCullough, R. Wolyn, and L.L. Rocher Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality Am J Med 103 1997 368 375
4. R. Mehran, E.D. Aymong, and E. Nikolsky A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 7 2004 1393 1399
5. S. Khanal, N. Attallah, and D.E. Smith Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions Am J Med 118 2005 843 849
6. M.S. Zhou, I.H. Schuman, E.A. Jaimes, and L. Raij Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability Am J Physiol Renal Physiol 295 1 2008 F53 F59
7. J. Xinwei, F. Xianghua, and Z. Jing Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol 104 4 2009 519 524
8. G. Patti, E. Ricottini, and A. Nusca Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty-contrast-induced nephropathy] tria Am J Cardiol 108 1 2011 1 7
9. G. Li, L. Yin, and T. Liu Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure Am J Cardiol 103 4 2009 512 514